Key statistics dashboard for Genprex, Inc. (GNPX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer.
Stock Data
| Price | $3.41 |
| Market Cap | $2M |
| Enterprise Value | -$13.4M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.02 |
| Price / Book | 0.11 |
| P/S | 0.00 |
| EV/EBITDA | 0.85 |
| EV/Sales | 0.00 |
| EV/FCF | 0.86 |
| P/FCF | -0.11 |
| Earnings Yield | -1022.54% |
| FCF Yield | -903.85% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -163.13% |
| Return on Assets | -96.27% |
| Return on Invested Capital | -107.08% |
| Return on Capital Employed | -107.08% |
Financial Health
| Current Ratio | 6.77 |
| Quick Ratio | 6.77 |
| Cash Ratio | 6.47 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Net Debt / EBITDA | 0.96 |
| Interest Coverage | -34.78 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -27.43 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 31.27 |
| Cash per share | 32.03 |
| FCF per share | -32.89 |
| Tangible Book Value per share | 31.27 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: BDRX · BIVI · CERO · CMMB · CNSP · GRI · INM
Explore sector: Healthcare · Biotechnology
More sections of GNPX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks